Reaction

Synovial Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 450 reports · 34 co-occurring drugs

As of the last recalculation, Synovial Disorder appears in 450 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is METHYLPREDNISOLONE ACETATE (PRR 192.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Methylprednisolone Acetate	31	192.2	193.0
Trimethoprim	28	117.1	117.4
Indomethacin	28	104.2	104.4
Esomeprazole Magnesium Capsule, Delayed Release	23	77.2	77.3
Esomeprazole Magnesium Delayed Release Capsules	23	77.2	77.3
Esomeprazole Magnesium Dihydrate	23	76.9	77.0
Sulfasalazine	94	70.0	70.1
Tofacitinib Citrate	19	69.9	70.0
Naproxen Sodium Tablet, Coated	18	64.0	64.1
Naproxen Sodium, Coated Tablets	18	64.0	64.1
Naproxen Sodium 220Mg	18	63.9	64.0
Naproxen	80	57.1	57.1
Pantoprazole Sodium In 0.9% Sodium Chloride	62	53.5	53.5
Pantoprazole Sodium Injection	62	53.5	53.5
Diclofenac Potassium, Film Coated	9	50.5	50.5
Diclofenac Potassium Tablets	9	50.4	50.5
Leflunomide	91	50.2	50.2
Hydrocortisone Sodium Succinate	9	45.2	45.2
Amitriptyline Hydrochloride	16	43.7	43.7
Hydroxychloroquine	58	41.1	41.1
Diclofenac Potassium	9	39.3	39.3
Adalimumab-Fkjp	33	35.5	35.5
Hydroxychloroquine Sulfate	60	35.0	35.0
Adalimumab-Aaty	33	34.7	34.7
Tofacitinib	106	34.5	34.5
Oxycodone And Acetaminophen Tablets	8	31.6	31.6
Dexlansoprazole	26	30.5	30.6
Cortisone Acetate	8	30.5	30.5
Empagliflozin	30	22.0	22.0
Golimumab	34	19.8	19.8
Pseudoephedrine Hydrochloride	4	18.2	18.2
Pseudoephedrine Hcl	4	16.9	16.9
Ranitidine Hydrochloride	18	15.9	15.9
Certolizumab Pegol	36	15.4	15.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.